-
NICE National Institute for Health and Care Excellence Highly Specialized Technology Evaluations: Use of Pivotal Clinical Trial Outcomes to Inform Relative Treatment Effect and Utilities
Sep 9, 2025, 16:22 PM -
An Initiative to Improve Patient Organization Engagement at the National Center for Pharmacoeconomics, Ireland
Sep 9, 2025, 16:22 PM -
Global Trade Shocks and Exchange Rate Effects on Pharmaceutical Reference Pricing: Implications of EU Stimulus for US MFN Policy
Sep 9, 2025, 16:22 PM -
Systematic Literature Review SLR Characterizing Humanistic Disease Burden and Unmet Needs in Erythropoietic Protoporphyria (EPP) and X-linked Protoporphyria (XLP)
Sep 9, 2025, 16:22 PM -
Navigating the Transition: What EU JCA Means for AMNOG Submissions in 2025 and Beyond
Sep 9, 2025, 16:22 PM -
Uncertainties in Regulatory Benefit-Risk Decision Making for Innovative Anticancer Therapies: Preliminary Results From a 2011-2024 Review of Extensions of Indications
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness Analysis of Aztreonam Avibactam (ATMAVI) ± Metronidazole (MTZ) for the Treatment of Complicated Intra-Abdominal Infections (cIAIs) and Ventilator-Associated Hospital-Acquired Pneumonia (HAP/VAP) Caused by Suspected MBL-Producing...
Sep 9, 2025, 16:22 PM -
Impact of Different CV Risk Estimation Methods on Cost-Effectiveness Analysis
Sep 9, 2025, 16:22 PM -
Shifts in Medicine Reimbursement in Türkiye: Who Pays for Medicines (2015-2022)?
Sep 9, 2025, 16:22 PM -
The Disease Burden of Systemic Sclerosis in the Russian Federation
Sep 9, 2025, 16:22 PM -
Comparison of the Early Access and Postmarket Evaluation Systems in South Korea and Germany’s DIGA
Sep 9, 2025, 16:22 PM -
Impact of Nirsevimab on the Health Burden and Costs of Respiratory Syncytial Virus (RSV) in the Infant Population From the Healthcare System in Argentina
Sep 9, 2025, 16:22 PM -
Evaluating the Impact of Subsequent Anticancer Therapy Use on Life-Year and QALY Estimates in Late-Line Metastatic Colorectal Cancer: A Health Economic Analysis of FRESCO-2
Sep 9, 2025, 16:22 PM -
Using Machine Learning to Enable Timely Postpartum Care by Reliably Detecting Deliveries
Sep 9, 2025, 16:22 PM -
Disease Management in Adults with Type 1 Diabetes Who Have a Prior Type 2 Diabetes Misdiagnosis and Recorded HbA1c in a US Managed Care Population
Sep 9, 2025, 16:22 PM -
Development of Cardiovascular Risk Equations: Integrating Clinical Expertise With Data From the SELECT Trial
Sep 9, 2025, 16:22 PM -
Clinical and Economic Burden Among Patients Requiring Long-Term Intermittent Catheter Use in England: A Real-World Retrospective Observational Cohort Study
Sep 9, 2025, 16:22 PM -
Lessons Learnt From PICO Exercise Developed by the Joint Clinical Assessment Subgroup for Etranacogene Dezaparvovec
Sep 9, 2025, 16:22 PM -
Building Risk-Sharing Agreements in Chile: Feasibility and Policy Options
Sep 9, 2025, 16:22 PM -
Worth Their Weight? Cost-Effectiveness and Access Decisions for GLP-1 and GIP/GLP-1 Therapies
Sep 9, 2025, 16:22 PM
